A status report on neuroscience research, without grade inflation

Annals of Neurology

Volumn 60, Issue 6, 2006, Pages

  Johnston, S Claiborne ^a   Hauser, Stephen L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; CREUTZFELDT JAKOB DISEASE; EDITORIAL; FUNDING; HUMAN; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROSCIENCE; PRIORITY JOURNAL;

ANIMALS; BIOMEDICAL RESEARCH; DRUG DESIGN; DRUG INDUSTRY; FINANCING, GOVERNMENT; FOUNDATIONS; HUMANS; NERVOUS SYSTEM DISEASES; NEUROSCIENCES; PUBLIC POLICY; RESEARCH; RESEARCH SUPPORT;

EID: 33846089338     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21054     Document Type: Editorial

References (10)

1. Dorsey ER, Vitticore P, de Roulet J, et al. Financial anatomy of neuroscience research. Ann Neurol 2006;60:652-659.
2. Moses III H, Martin JB. What should be done to improve the productivity of neurological research? Ann Neurol 2006;60: 647-651.
3. Johnston SC, Hauser SL. Can industry rescue the NIH? Ann Neurol 2006;60:A11-A14.
4. Wood AJ. A proposal for radical changes in the drug-approval process. N Engl J Med 2006;355:618-623.
5. Alzheimer's Disease Neuroimaging Study Launched Nationwide by the National Institutes of Health. Vol. 2006. Bethesda, MD: National Institute on Aging, 2006.
6. Marshall E. U.K. science. Industry-academic drug screening plan targets CJD. Science 2005;308:477.
7. Louet S. Public-private partnerships boost research on neglected diseases. Nat Biotechnol 2003;21:1254-1255.
8. The UC Discovery Program. Vol. 2006. Berkeley, CA: The Industry-University Cooperative Research Program (IUCRP), Accessed Oct 31, 2006.
9. Hauser SL, McArthur JC. Saving the clinician-scientist: report or the ANA long range planning committee. Ann Neurol 2006; 60:278-285.
10. Adapted from comments by Haile Debas, MD.